COVID-19 vaccination safe for pregnant women with autoimmune disordersJune 1st 2023
Adverse events were significantly more frequently reported by pregnant patients when compared with non-pregnant patients. However, no differences were observed when comparing pregnant patients with autoimmune disease and healthy controls.
Tofacitinib-treated women with PsA less likely to achieve MDAApril 4th 2023
At month 3, patients treated with tofacitinib achieved higher rates of ACR20/50, MDA, and PASI75 in both sexes when compared with the placebo. However, female patients were less likely to achieve MDA when compared with males.